Clinical trial
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
NCT00444600 · Jaeb Center for Health Research, Other · Completed
Key facts
| NCT number | NCT00444600 |
|---|---|
| Title | Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema |
| Official title | Intravitreal Ranibizumab or Triamcinolone Acetonide in Combination With Laser Photocoagulation for Diabetic Macular Edema |
| Acronym | LRT for DME |
| Lead sponsor | Jaeb Center for Health Research, Other |
| Collaborators | National Eye Institute (NEI) NIH Allergan Industry Genentech, Inc. |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy, Diabetic Macular Edema |
| Intervention type | Drug |
| Interventions | Triamcinolone Acetonide + laser, Ranibizumab + laser, Sham injection + laser, Ranibizumab + deferred laser |
| Enrollment | 691 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Feb 1, 2014 |
| First posted | Mar 8, 2007 |
| Last update posted | Oct 7, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: